Elastin fragments induce IL-1beta upregulation via NF-kappaB pathway in melanoma cells
Romain Debret1, Richard R Le Naour, Jean-Michel Sallenave
1Department of Dermatology, CNRS UMR 6198 Faculty of Medicine, University of Reims, Champagne-Ardenne, France.
Abstract:
In a previous work, we reported the influence of elastin fragments (EFs) on matrix metalloproteinases-2 and -14 expression and activation in melanoma cells in vitro. We hypothesized that EFs might also modulate expression of other mediators involved during melanoma progression. Therefore we investigated the contribution of EFs on IL-1beta expression, a cytokine playing a key role in melanoma cells activation. Our results evidenced that high tumorigenic melanoma cells (M3Da cells) treated with EFs led to IL-1beta mRNA and protein upregulation. The effects of EFs on M3Da cells were found to be mediated by receptor (spliced galactosidase) occupancy, as being suppressed by lactose and reproduced by cell stimulation with the VGVAPG peptide. Binding of EFs to their receptor induced a rapid activation of extracellular signal-regulated kinase 1/2; and p38 mitogen-activated protein kinase pathways. However, these pathways were not associated with IL-1beta mRNA upregulation by EFs. Concomitantly, we demonstrated that EFs stimulation induced NF-kappaB nuclear translocation and DNA binding on IL-1beta promoter region whereas inhibition of NF-kappaB with the specific chemical inhibitor SN-50 or by overexpression of IkappaB, the endogenous inhibitor of NF-kappaB pathway, totally abolished EFs-mediated IL-1beta mRNA overexpression. These results demonstrate that EFs induce NF-kappaB activation, leading to IL-1beta upregulation in invasive melanoma cells.
Insights
Elastin fragments (EFs) upregulate IL-1beta in invasive melanoma cells. This process involves NF-kappaB activation, a key pathway in melanoma progression and cytokine expression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Elastin fragments (EFs) influence melanoma cell behavior.
- IL-1beta is a key cytokine in melanoma activation and progression.
Purpose of the Study:
- Investigate the role of EFs in IL-1beta expression in melanoma cells.
- Elucidate the molecular mechanisms by which EFs modulate IL-1beta.
Main Methods:
- Treatment of high tumorigenic melanoma cells (M3Da) with EFs.
- Assessing IL-1beta mRNA and protein levels.
- Investigating receptor-mediated effects using lactose and VGVAPG peptide.
- Analyzing extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (MAPK) pathways.
- Examining NF-kappaB pathway activation through nuclear translocation and DNA binding assays.
- Utilizing NF-kappaB inhibition via SN-50 or IkappaB overexpression.
Main Results:
- EFs treatment led to significant IL-1beta mRNA and protein upregulation in M3Da cells.
- EFs effects were receptor-mediated, involving spliced galactosidase, and mimicked by VGVAPG peptide.
- While ERK1/2 and p38 MAPK pathways were activated, they were not linked to IL-1beta upregulation.
- EFs induced NF-kappaB nuclear translocation and DNA binding to the IL-1beta promoter.
- Inhibition of NF-kappaB completely abolished EFs-induced IL-1beta mRNA overexpression.
Conclusions:
- Elastin fragments stimulate NF-kappaB activation in invasive melanoma cells.
- This NF-kappaB activation results in the upregulation of IL-1beta, contributing to melanoma progression.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply

